Submitted by Anonymous (not verified) on 16 January 2026 - 15:32
Human medicines European public assessment report (EPAR): Elrexfio, elranatamab, Date of authorisation: 07/12/2023, Revision: 5, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Elrexfio, elranatamab, Date of authorisation: 07/12/2023, Revision: 5, Status: Authorised